Evidence map›Paper›PMID 30603243›Full record

ArticleDiabetology international2016

Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance.

Kazuhiko Sakaguchi, Kazuo Takeda, Mitsuo Maeda, Wataru Ogawa, Toshiyuki Sato, Seiki Okada, Yasuhito Ohnishi, Hiromu Nakajima, Atsunori Kashiwagi

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Diabetology international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03607799 naactive not recruitingnot on this mapstarted 2020, after this paper: background citation

A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes Mellitus

TypeinterventionalSponsorMcMaster UniversityRan2020 to 2025Enrolled140ConditionsDiabetes, GestationalArmsDietary Intervention, Control
NCT06895161 nacompletednot on this mapstarted 2025, after this paper: background citation

Effectiveness of Home-Based Tele-Exercise vs Center-Based Exercise Programs in Patients With Prediabetes: A Comparative Study

TypeinterventionalSponsorGazi UniversityRan2025 to 2025Enrolled42ConditionsPrediabetes, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), TelemedecineArmsRemotely supervised exercise at home or outdoors, Hospital-based exercise program, Phone calls with reinforcement feedback
3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 152 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Role of Exercise in Fat Oxidation and Its Impact on Adolescent Metabolism.Advances in experimental medicine and biology · 2026
    Review
  12. Article
  13. Article
  14. Journal of agricultural and food chemistry · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kazuhiko Sakaguchi1Division of Diabetes, Metabolism and Endocrinology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Kazuo TakedaKyoto Industrial Health Association, Kyoto, Japan.
Mitsuo MaedaIHI Harima Hospital, Aioi, Japan.
Wataru Ogawa1Division of Diabetes, Metabolism and Endocrinology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017 Japan.
Toshiyuki Sato4Sysmex Corporation, Kobe, Japan.
Seiki Okada4Sysmex Corporation, Kobe, Japan.
Yasuhito Ohnishi4Sysmex Corporation, Kobe, Japan.
Hiromu Nakajima5Department of Clinical Laboratory, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Atsunori KashiwagiKusatsu General Hospital, Shiga, Japan.
Sysmex (Japan) · JPJapan Industrial Safety and Health Association · JPKobe University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

HbA1c and fasting plasma glucose (FPG) levels are commonly recognized as diagnostic indices for diabetes and glucose intolerance. However, they are not sufficient for clear detection of glucose intolerance in the early stage unless an oral glucose tolerance test (OGTT) is performed. Moreover, even in case of an OGTT, 2-h postprandial plasma glucose (PG) levels, a criterion for glucose intolerance in OGTTs, may not provide complete information regarding glucose tolerance. Whole glucose excursion after OGTT is considered to represent glucose tolerance well, and the glucose area under the curve (AUC) can be an index of glucose excursion. However, few studies have investigated measurement of the glucose AUC in glucose intolerance screening. In the present study, data from 520 OGTTs were analyzed to define the cutoff value for the glucose AUC for glucose intolerance screening. Our results showed that a cutoff value of 290 mg h/dl for the glucose AUC was highly sensitive and specific (90 and 93 %, respectively) for detecting diabetes, impaired glucose tolerance (IGT), and group at increased risk of diabetes (normal glucose tolerance with 1-h PG levels of ≥180 mg/dl after glucose load) and showed a better concordance rate than the use of HbA1c, FPG, or 2-h PG levels. Moreover, the cutoff value for the glucose AUC calculated using the diagnostic criteria in the OGTT (305 mg h/dl) was consistent with the value determined from OGTT analysis. These data suggest a possibility that glucose intolerance screening using a glucose AUC cutoff value of 290 mg h/dl could be useful.

Indexed as

Glucose area under the curveGlucose intoleranceOral glucose tolerance testScreening

Identifiers

PMID30603243
PMCPMC6214468
OpenAlexW316595173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.